A new "liquid biopsy" blood test could revolutionise cancer treatment by allowing doctors to track how tumours are responding to treatment without the need for surgery, a study claims.
BIVDA is responding to the recent Department of Health consultation on patient choice in diagnostic testing.
Policy & Media
BIVDA Press Releases
Click here to view more of our Parliamentary Newsletters
© 2015 BIVDA Ltd is registered in England, with Company Number 2687137
Registered Office is Devonshire House (2nd floor), 164-168 Westminster Bridge Road, London, SE1 7RW VAT Number 563105858